期刊文献+

急性冠状动脉综合征患者血清hs-CRP水平与冠状动脉病变的相关性 被引量:6

Correlation of high sensitive C-reactive protein with Gensini score in patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨急性冠脉综合征(ACS)患者血清超敏C-反应蛋白(hs-CRP)水平与冠状动脉病变程度的关系及临床意义。方法 60例急性冠脉综合征患者(30例AMI患者和30例UAP患者)作为研究组,30例健康体检者作为对照组;所有人均取外周静脉血检测血清超敏C-反应蛋白(hs-CRP)。冠状动脉病变按Gensini评分,分析血清超敏C-反应蛋白(hs-CRP)水平与Gensini评分的关系。结果与对照组比较,研究组hs-CRP明显增高,差异有统计学意义(P<0.01);AMI组和UAP组Gensini评分的差异具有统计学意义(P<0.01);相关性检验显示ACS患者血清hs-CRP水平与Gensini评分成正相关(r=0.722,P<0.01)。结论急性冠脉综合征患者血清超敏C-反应蛋白(hs-CRP)水平与冠状动脉病变程度密切相关,提示hs-CRP可作为评估ACS病情严重程度的一个指标。 Objective To investigate the correlation between high sensitive C-reactive protein(hs-CRP)in serum and Gensini score in patients with acute coronary syndrome (ACS). Methods Sixty patients with ACS were enrolled in this study, including 30 patients with acute myocardial infarction(AMI) and 30 patients with unstable angina pectoris(UAP). Thirty healthy subjects were chosen as controls. The lesions of coronary arteries were assessed. The relation of the serum level of hs-CRP with Gensini score was analyzed. Results The level of hs-CRP in serum was significantly higher in ACS group than that in control group (P 〈 0.01 ). Gensini score was significantly higher in AMI group than that in UAP group (P 〈 0.01 ). The level of hs-CRP was positively related with Gensini score in ACS patients (r = 0.722 ,P 〈 0.01 ). Conclusion Serum levels of high sensitive C-reactive protein in patients with ACS is closely related to the atherosclerostic lesions of coronary arteries, which suggests that hs-CRP may be an indicator to evaluate the severity of ACS.
出处 《山西医科大学学报》 CAS 2013年第4期291-293,共3页 Journal of Shanxi Medical University
关键词 急性冠脉综合征 超敏C-反应蛋白 GENSINI评分 相关性 acute coronary syndrome high sensitive C-reactive protein Gensini score correlation
  • 相关文献

参考文献12

  • 1Libby P. Molecular bases of the acute coronary syndromes [ J].Circulation, 1995 ,91:2844 -2850.
  • 2刘建民,李金珉,胡燕燕,刘平.急性冠脉综合征患者血清C反应蛋白和白细胞介素10的水平及其意义[J].心血管康复医学杂志,2009,18(2):130-133. 被引量:7
  • 3曹宇,杨侃,蒋卫红,肖丽.血清hs-CRP与冠状动脉病变严重程度的相关性研究[J].实用预防医学,2003,10(4):504-506. 被引量:7
  • 4Gensini GG. A more meaningful scoring system for determining theseverity of coronary heart disease [ J ]. Am J Cardiol, 1983,51(6):605 - 606.
  • 5李田昌.急性冠脉综合征的危险分层和处理[M].//胡大一,马长生.心脏病学实践2004-规范化治疗.北京:人民卫生出版社,2004:780-786.
  • 6Legeys VA. The use of high sensitivity C-reactive protein in asses-sing the risk for coronary heart disease[ J] . Clin Lab Set,2001,14(4) :243 -246.
  • 7Steel DM,Whitehead AS. The major acute phase reactant:C reac-tive protein, serum amyloid P component and serum amyloid aprotein[ J]. Immunol Today ,2006,15(9) :81 -88.
  • 8Singh SK,SureshMV,Voleti B,et al. The connection between C-reactive protein and atherosclerosis[ J]. Ann Med,2008,40(2):110-120.
  • 9Buck C,Bundschu J,Gallati H,ei al. Interleukin 6:a sensitive pa-rameter for early diagnosis of neonatal bacterial infection [ J ]. Pedi-atrics,2007,93(7) :54-58.
  • 10Momiyama Y, Ohmori R, Fayad ZA^et al. Associations betweenplasma c-reactive protein levels and the severities of coronary andaortic atheroselerosis [ J]. J Atheroscler Thromb,2010,17(5):460-467.

二级参考文献18

  • 1CHEN Yu-guo,XU Feng,ZHANG Yun,JI Qiu-shang,SUN Yi,LUE Rui-juan,LI Rui-jian.EFFECT OF ASPIRIN PLUS CLOPIDOGREL ON INFLAMMATORY MARKERS IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME[J].Chinese Medical Journal,2006(1):32-36. 被引量:25
  • 2Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient : a call for new definitions and risk assessment strategies: Part Ⅰ [J]. Circulation, 2003, 108 (14):1664- 1672.
  • 3Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part Ⅱ: acute-phase reactants and biomarkers of endothelial cell activation [J]. Circulation, 2006, 113 (1): 152--155.
  • 4Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983, 51 (3): 606.
  • 5Heeschen C, Dimmeler S, Harem CW, et al. Serum level of the anti,inflammatory eytokine interleukin-- 10 is an important prognostic determinant in patients with acre coronary syndromes [J]. Circlation, 2003, 107 (16):2109-2114.
  • 6Smith DA, Irving SD, Sheldon J, et al. Serum levels of the anti-inflammatory cytokine interleukin-- 10 are decreased in patients with unstable angina [J]. Circulation,2001,104(7) : 746 - 749.
  • 7Tziakas DN, Chalikias GK, Hatzinikolaou HI, et al. Anti-inflammatory eytokine profile in acute coronary syndromes: behavior of interleukin--10 in association with serum metalloproteinases and proinflammatory eyotokines [J]. Int J Cardiol, 2003, 92 (1)~ 169--175.
  • 8Singh U, Devaraj S, Dasu MR, et al. C--reactive protein decreases interleukin-- 10 secretion in activated human monocytederived macrophages via cyclic AMP production [J]. Arterioscler Thromb Vasc Biol, 2006, 26 (11): 2469--2475.
  • 9Tziakas DN, Chalikias GK, Kaski JC, et al. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a tactor analysis approach [J]. Atherosclerosis, 2007, 193 (1) : 196--203.
  • 10Auer J. Berent R, Lassnig E,et al. C--reactive protein and coronary artery disease[J], Jpn Heart J, 2002,43 (6) : 607-619.

共引文献52

同被引文献62

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部